Some of these medications are commonly used in the United States (1, If you have G6PD deficiency, its important to talk with your doctor and pharmacist about which medications you should avoid or use with extra caution ( Acetaminophen: an analgesic (pain-relieving) drug Acetylsalicylic acid (aspirin): an anti-inflammatory drug Chloramphenicol: an antibiotic drug Chloroquine: an immunosuppressant and antimalarial drug Colchicine: a gout medication Diaminodiphenyl sulfone (Dapsone): an antibiotic and antimalarial drug Diclofenac sodium: an anti-inflammatory drug Diphenhydramine: an antihistamine drug Glyburide: a diabetes drug Ibuprofen: an anti-inflammatory drug Izoniazid: an antibiotic drug L-dopa: a Parkinsons disease treatment Methylene blue: a dye and blood disorder treatment Nitrofurantoin: an antimicrobial drug Phenazopyridine: an analgesic drug Primaquine: an antimalarial drug Rasburicase: a gout medication Streptomycin: an antibiotic drug Sulfa drugs: a group of antibiotics that includes co-trimoxazole, sulfacetamide, and trimethoprim Tripelennamine: an antihistamine drug Vitamin K: a dietary supplement A 2019 review also suggests caution if using herbal supplements or extracts containing Rhizoma coptidis (also called Huang Lian) or Coptis chinensis
Additional at-risk groups include: Vegans and strict vegetarians , who may have low dietary B12 intake People with autoimmune conditions , including pernicious anaemia or type 1 diabetes Individuals with gastrointestinal conditions such as Crohn's disease or coeliac disease, which impair nutrient absorption People who have undergone bariatric surgery , which can significantly reduce B12 absorption Long-term users of proton pump inhibitors (PPIs) or H2-receptor antagonists , which reduce gastric acid and impair B12 release from food Those with a family history of either pernicious anaemia or diabetes For these groups, simultaneous monitoring of B12 status and glycaemic markers is particularly important to avoid diagnostic errors
About GLP-1s Transform Your Health Through Medical Weight Loss at Refresh Learn more about GLP-1 Medication At Refresh Aesthetics, we know that weight loss is more than just a number on the scale
Liver Disease: MASLD and NAFLD Metabolic dysfunction-associated steatotic liver disease (MASLD formerly NAFLD) affects approximately 1 in 3 UK adults with obesity
Cardiometabolic outcomes have taken center stage, with clinical trials tracking secondary and composite endpoints beyond weight loss
